company background image
AT1

Atomo Diagnostics ASX:AT1 Stock Report

Last Price

AU$0.055

Market Cap

AU$31.4m

7D

0%

1Y

-74.4%

Updated

28 Jan, 2023

Data

Company Financials

AT1 Stock Overview

Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide.

AT1 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

My Notes

New

Notes are coming soon

Atomo Diagnostics Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Atomo Diagnostics
Historical stock prices
Current Share PriceAU$0.055
52 Week HighAU$0.23
52 Week LowAU$0.053
Beta0.96
1 Month Change1.85%
3 Month Change-9.84%
1 Year Change-74.42%
3 Year Changen/a
5 Year Changen/a
Change since IPO-85.90%

Recent News & Updates

We Think Atomo Diagnostics (ASX:AT1) Can Afford To Drive Business Growth

Oct 10
We Think Atomo Diagnostics (ASX:AT1) Can Afford To Drive Business Growth

Is Atomo Diagnostics (ASX:AT1) In A Good Position To Invest In Growth?

Jun 10
Is Atomo Diagnostics (ASX:AT1) In A Good Position To Invest In Growth?

Recent updates

We Think Atomo Diagnostics (ASX:AT1) Can Afford To Drive Business Growth

Oct 10
We Think Atomo Diagnostics (ASX:AT1) Can Afford To Drive Business Growth

Is Atomo Diagnostics (ASX:AT1) In A Good Position To Invest In Growth?

Jun 10
Is Atomo Diagnostics (ASX:AT1) In A Good Position To Invest In Growth?

We're Not Worried About Atomo Diagnostics' (ASX:AT1) Cash Burn

Dec 06
We're Not Worried About Atomo Diagnostics' (ASX:AT1) Cash Burn

Atomo Diagnostics Limited (ASX:AT1) Shares Could Be 50% Below Their Intrinsic Value Estimate

Nov 01
Atomo Diagnostics Limited (ASX:AT1) Shares Could Be 50% Below Their Intrinsic Value Estimate

We're Interested To See How Atomo Diagnostics (ASX:AT1) Uses Its Cash Hoard To Grow

Jul 19
We're Interested To See How Atomo Diagnostics (ASX:AT1) Uses Its Cash Hoard To Grow

Market Sentiment Around Loss-Making Atomo Diagnostics Limited (ASX:AT1)

Feb 26
Market Sentiment Around Loss-Making Atomo Diagnostics Limited (ASX:AT1)

Atomo Diagnostics (ASX:AT1) Is In A Strong Position To Grow Its Business

Jan 22
Atomo Diagnostics (ASX:AT1) Is In A Strong Position To Grow Its Business

Here's What Atomo Diagnostics Limited's (ASX:AT1) Shareholder Ownership Structure Looks Like

Dec 18
Here's What Atomo Diagnostics Limited's (ASX:AT1) Shareholder Ownership Structure Looks Like

When Can We Expect A Profit From Atomo Diagnostics Limited (ASX:AT1)?

Jul 16
When Can We Expect A Profit From Atomo Diagnostics Limited (ASX:AT1)?

Shareholder Returns

AT1AU Medical EquipmentAU Market
7D0%-2.4%0.6%
1Y-74.4%2.2%3.5%

Return vs Industry: AT1 underperformed the Australian Medical Equipment industry which returned 2.2% over the past year.

Return vs Market: AT1 underperformed the Australian Market which returned 3.5% over the past year.

Price Volatility

Is AT1's price volatile compared to industry and market?
AT1 volatility
AT1 Average Weekly Movement5.5%
Medical Equipment Industry Average Movement9.7%
Market Average Movement8.5%
10% most volatile stocks in AU Market15.7%
10% least volatile stocks in AU Market3.5%

Stable Share Price: AT1 is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: AT1's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2010n/aJohn Kellyhttps://atomodiagnostics.com

Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide. It offers rapid diagnostic test devices for COVID-19, HIV screening, pregnancy test, and respiratory test. The company was incorporated in 2010 and is headquartered in Leichhardt, Australia.

Atomo Diagnostics Limited Fundamentals Summary

How do Atomo Diagnostics's earnings and revenue compare to its market cap?
AT1 fundamental statistics
Market CapAU$31.40m
Earnings (TTM)-AU$5.71m
Revenue (TTM)AU$12.34m

2.5x

P/S Ratio

-5.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
AT1 income statement (TTM)
RevenueAU$12.34m
Cost of RevenueAU$8.45m
Gross ProfitAU$3.88m
Other ExpensesAU$9.59m
Earnings-AU$5.71m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.01
Gross Margin31.48%
Net Profit Margin-46.26%
Debt/Equity Ratio0%

How did AT1 perform over the long term?

See historical performance and comparison